The EC signed the framework agreement after a request from six participating countries, including Austria, Denmark, Ireland, Luxembourg, Norway, and Portugal.
Sentante’s platform enables clinicians to perform endovascular procedures remotely through a teleoperated workstation equipped with haptic feedback controls and multiple operating room displays.
The approval grants the pharmaceutical giant the right to market Enflonsia across all 27 member states of the European Union, as well as Iceland, Liechtenstein, and Norway.
LumiGuide enables physicians to visualize and guide devices inside the body using light instead of continuous X-ray imaging.